Vera Therapeutics (VERA) Net Income Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -131.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -131.57% |
| Dec 31, 2025 | -199.45% |
| Sep 30, 2025 | -70.63% |
| Jun 30, 2025 | -121.65% |
| Mar 31, 2025 | -80.63% |
| Dec 31, 2024 | 63.46% |
| Sep 30, 2024 | -128.69% |
| Jun 30, 2024 | -65.42% |
| Mar 31, 2024 | 5.50% |
| Dec 31, 2023 | 43.21% |
| Sep 30, 2023 | 17.25% |
| Jun 30, 2023 | -38.35% |
| Mar 31, 2023 | -78.28% |
| Dec 31, 2022 | 334.44% |
| Sep 30, 2022 | -242.54% |
| Jun 30, 2022 | -155.21% |
| Mar 31, 2022 | -263.03% |
| Dec 31, 2021 | 61.01% |
| Sep 30, 2021 | -76.71% |
| Jun 30, 2021 | -80.69% |
| Mar 31, 2021 | -89.39% |